Company
Bolt Biotherapeutics, Inc. (BOLT)
Standardized SEC financial data for Bolt Biotherapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001641281 · NASDAQ · Pharmaceutical Preparations.
Operating margin
-469.3%
Net margin
-433.7%
Revenue growth (YoY)
0.1%
Return on equity
-125.9%
Free cash flow
-$39.9M
Current ratio
3.59×
EPS (diluted)
$-17.85
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $231K | $1.3M | $5.7M | $7.9M | $7.7M | $7.7M |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $7.1M | $28.9M | $192.8M | $128.6M | $70.2M | $31.8M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$47.3M | -$57.1M | -$76.5M | -$69.5M | -$61.3M | -$39.9M |
| Capital expenditures |
Get BOLT data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/BOLT/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/BOLT/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"